Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lærke Kjær Tolstrup"'
Autor:
Lærke Kjær Tolstrup, Karin B. Dieperink, Marieke van Leeuwen, Sören Möller, Linnea Fechner, Line Helene Clausen, Thea Otto Mattsson
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Purpose: The Region of Southern Denmark has recently established four late effects clinics to help cancer survivors suffering from complex and severe late effects. This study aimed to capture and analyze the full range of physical, mental, and psycho
Externí odkaz:
https://doaj.org/article/81a6380be1164522aaabf4b438e7bd65
Publikováno v:
Digital Health, Vol 9 (2023)
Objective To investigate the feasibility of clinical assessment and decision of treatment readiness before chemotherapy using video consultations, as perceived by gastrointestinal cancer patients and oncology nurses. In addition, to estimate reductio
Externí odkaz:
https://doaj.org/article/f9bd6857dc9649008704a0487a023259
Autor:
Niels Henrik I. Hjollund, Louise Pape Larsen, Annette Ladefoged de Thurah, Birgith Engelst Grove, Halla Skuladottir, Hanne Linnet, Rasmus Blechingberg Friis, Søren Paaske Johnsen, Ole May, Annesofie Lunde Jensen, Troels Krarup Hansen, Gry Assam Taarnhøj, Lærke Kjær Tolstrup, Helle Pappot, Per Ivarsen, Liv Dørflinger, Anne Jessen, Nanna Toxvig Sørensen, Liv Marit Valen Schougaard, The AmbuFlex team
Publikováno v:
Hjollund, N H I, Larsen, L P, de Thurah, A L, Grove, B E, Skuladottir, H, Linnet, H, Friis, R B, Johnsen, S P, May, O, Jensen, A L, Hansen, T K, Taarnhøj, G A, Tolstrup, L K, Pappot, H, Ivarsen, P, Dørflinger, L, Jessen, A, Sørensen, N T, Schougaard, L M V & Team, T A 2023, ' Patient-reported outcome (PRO) measurements in chronic and malignant diseases : ten years' experience with PRO-algorithm-based patient-clinician interaction (telePRO) in AmbuFlex ', Quality of Life Research, vol. 32, no. 4, pp. 1053-1067 . https://doi.org/10.1007/s11136-022-03322-9
Background Patient-reported Outcome (PRO) measures may be used as the basis for out-patient follow-up instead of fixed appointments. The patients attend follow-up from home by filling in questionnaires developed for that specific aim and patient grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebdefd927c6a5f34f6c5b56241225d79
https://vbn.aau.dk/da/publications/07951fa2-17fb-48b1-8f18-360420294c75
https://vbn.aau.dk/da/publications/07951fa2-17fb-48b1-8f18-360420294c75
Autor:
Lærke Kjær Tolstrup, Anne Birgitte Als, Andreas Carus, Rikke Dahlrot, Line Hammer Dohn, Cecilie Holländer-Mieritz, Gry Taarnhøj, Helle Pappot
Publikováno v:
Tolstrup, L K, Als, A B, Carus, A, Dahlrot, R, Dohn, L H, Holländer-Mieritz, C, Taarnhøj, G & Pappot, H 2023, ' The iBLAD app protocol–a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care ', Acta Oncologica, vol. 62, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2023.2194031
Tolstrup, L K, Als, A B, Carus, A, Dahlrot, R, Dohn, L H, Holländer-Mieritz, C, Taarnhøj, G & Pappot, H 2023, ' The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care ', Acta Oncologica, vol. 62, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2023.2194031
Tolstrup, L K, Als, A B, Carus, A, Dahlrot, R, Dohn, L H, Holländer-Mieritz, C, Taarnhøj, G & Pappot, H 2023, ' The iBLAD app protocol – a national, exploratory study on a multimodality smartphone app in bladder cancer for better understanding symptoms, quality of life and need for supportive care ', Acta Oncologica, vol. 62, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2023.2194031
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f47808e785bc622e7b1bb6fc968cd8b6
https://pure.au.dk/portal/da/publications/the-iblad-app-protocola-national-exploratory-study-on-a-multimodality-smartphone-app-in-bladder-cancer-for-better-understanding-symptoms-quality-of-life-and-need-for-supportive-care(e00dc9bb-f897-4662-8bf4-84d250af2f1e).html
https://pure.au.dk/portal/da/publications/the-iblad-app-protocola-national-exploratory-study-on-a-multimodality-smartphone-app-in-bladder-cancer-for-better-understanding-symptoms-quality-of-life-and-need-for-supportive-care(e00dc9bb-f897-4662-8bf4-84d250af2f1e).html
Autor:
Lærke Kjær Tolstrup, Helena Møgelbjerg Ditzel, Ann-Kristine Weber Giger, Trine Lembrecht Jørgensen, Jesper Ryg, Karin Brochstedt Dieperink
Publikováno v:
Journal of Geriatric Oncology. 14:101500
Autor:
Bart Neyns, Alfredo Addeo, Helle Pappot, Sandrine Aspeslagh, André Manuel da Silva Lopes, Olivier Michielin, Gilliosa Spurrier-Bernard, Manuela Eicher, Anne Rogiers, John B. A. G. Haanen, Nuria Neisy Mederos Alfonso, Sara Colomer-Lahiguera, Veronica Aedo-Lopez, Lærke Kjær Tolstrup, Sandra A. Mitchell
Publikováno v:
Da Silva Lopes, A M, Colomer-Lahiguera, S, Mederos Alfonso, N, Aedo-Lopez, V, Spurrier-Bernard, G, Tolstrup, L K, Pappot, H, Aspeslagh, S, Rogiers, A, Neyns, B, Haanen, J B, Mitchell, S A, Addeo, A, Michielin, O & Eicher, M 2021, ' Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors : A Delphi study ', European Journal of Cancer, vol. 157, pp. 225-237 . https://doi.org/10.1016/j.ejca.2021.08.026
Background Immune-related adverse events (IrAEs) associated with the use of immune checkpoint inhibitors (ICIs) may not be fully covered by existing measures like the PRO-CTCAE™. Selecting PRO-CTCAE™ items for monitoring symptomatic adverse event
Autor:
Lars Bastholt, Helle Pappot, Sören Möller, Lærke Kjær Tolstrup, Karin Brochstedt Dieperink, Ann-Dorthe Zwisler
Publikováno v:
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-10 (2020)
Tolstrup, L K, Bastholt, L, Dieperink, K B, Möller, S, Zwisler, A D & Pappot, H 2020, ' The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy : a randomized controlled pilot trial ', Journal of patient-reported outcomes, vol. 4, 88 . https://doi.org/10.1186/s41687-020-00255-0
Tolstrup, L K, Bastholt, L, Dieperink, K B, Möller, S, Zwisler, A D & Pappot, H 2020, ' The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy : a randomized controlled pilot trial ', Journal of Patient-Reported Outcomes, vol. 4, no. 1, 88 . https://doi.org/10.1186/s41687-020-00255-0
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-10 (2020)
Tolstrup, L K, Bastholt, L, Dieperink, K B, Möller, S, Zwisler, A D & Pappot, H 2020, ' The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy : a randomized controlled pilot trial ', Journal of patient-reported outcomes, vol. 4, 88 . https://doi.org/10.1186/s41687-020-00255-0
Tolstrup, L K, Bastholt, L, Dieperink, K B, Möller, S, Zwisler, A D & Pappot, H 2020, ' The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy : a randomized controlled pilot trial ', Journal of Patient-Reported Outcomes, vol. 4, no. 1, 88 . https://doi.org/10.1186/s41687-020-00255-0
Background A randomized controlled pilot trial was conducted to assess if melanoma patients treated with immunotherapy had the number of grade 3 or 4 adverse events during treatment reduced by 50% using a tailored electronic patient-reported outcomes
Autor:
J.B.A.G. Haanen, G. Spurrier-Bernard, Alfredo Addeo, Anne Rogiers, S. Colomer-Lahiguera, Lærke Kjær Tolstrup, Olivier Michielin, V Aedo Lopez, Bart Neyns, Helle Pappot, Sandra A. Mitchell, Sandrine Aspeslagh, N-N. Mederos-Alfonso, A.M.D.S. Lopes, Manuela Eicher
Publikováno v:
Annals of Oncology. 32:S1180
Publikováno v:
Dieperink, K B, Ikander, T, Appiah, S & Tolstrup, L K 2021, ' The cost of living with cancer during the second wave of COVID-19 : A mixed methods study of Danish cancer patients' perspectives ', European Journal of Oncology Nursing, vol. 52, 101958 . https://doi.org/10.1016/j.ejon.2021.101958
Purpose: This study investigated experiences and levels of distress and resilience of Danish cancer patients during the second wave of the COVID-19 pandemic. Methods: The mixed methods design included a subset of cancer patients who responded to a cr
Autor:
Lars Bastholt, Ann-Dorthe Zwisler, Karin Brochstedt Dieperink, Lærke Kjær Tolstrup, Helle Pappot
Publikováno v:
Tolstrup, L K, Bastholt, L, Zwisler, A D O, Dieperink, K B & Pappot, H 2019, ' Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy ', Journal of patient-reported outcomes, vol. 3, 19 . https://doi.org/10.1186/s41687-019-0111-8
Journal of Patient-Reported Outcomes
Tolstrup, L K, Bastholt, L, Zwisler, A D, Dieperink, K B & Pappot, H 2019, ' Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy ', Journal of Patient-Reported Outcomes, vol. 3, 19 . https://doi.org/10.1186/s41687-019-0111-8
Tolstrup, L K, Bastholt, L, Dieperink, K B, Zwisler, A D O & Pappot, H 2018, ' Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy ', Multinational Association of Supportive Care in Cancer, Wien, Austria, 27/06/2018-30/06/2018 .
University of Southern Denmark
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-7 (2019)
Journal of Patient-Reported Outcomes
Tolstrup, L K, Bastholt, L, Zwisler, A D, Dieperink, K B & Pappot, H 2019, ' Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy ', Journal of Patient-Reported Outcomes, vol. 3, 19 . https://doi.org/10.1186/s41687-019-0111-8
Tolstrup, L K, Bastholt, L, Dieperink, K B, Zwisler, A D O & Pappot, H 2018, ' Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy ', Multinational Association of Supportive Care in Cancer, Wien, Austria, 27/06/2018-30/06/2018 .
University of Southern Denmark
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-7 (2019)
CONTEXT: Toxicity-monitoring plays an important role in all cancer treatment, however, early recognition is vital for detecting and treating immune-related symptoms. Preparing a Patient Reported Outcomes tool and including melanoma patients receiving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea6c5f4fc58a6f7c91672e717a8696b
https://findresearcher.sdu.dk:8443/ws/files/151563373/Selection_of_patient_reported_outcomes_questions_reflecting_symptoms_for_patients_with_metastatic_melanoma_receiving_immunotherapy.pdf
https://findresearcher.sdu.dk:8443/ws/files/151563373/Selection_of_patient_reported_outcomes_questions_reflecting_symptoms_for_patients_with_metastatic_melanoma_receiving_immunotherapy.pdf